HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies

Journal of Immunology

Volumn 161, Issue 12, 1998, Pages 6705-6714

  Burlingham, William J ^a   Jankowska Gan, Ewa ^a   DeVito Haynes, Lynn ^a   Fechner Jr , John H ^a   Hogan, Kevin T ^b   Claas, Frans H J ^c   Mulder, Arend ^c,d   Wang, Xinhui ^e   Ferrone, Soldano ^e  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Argonex Pharmaceuticals   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d SVM Found Adv Pub Hlth E   (Netherlands)

^e NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; IDIOTYPIC ANTIBODY; MONOCLONAL ANTIBODY; ALLOANTIBODY; ANTIIDIOTYPIC ANTIBODY; EPITOPE; HLA A2 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; HLA SYSTEM; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNIZATION; IMMUNOGENETICS; IMMUNOGLOBULIN VARIABLE REGION; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; ALLELE; AMINO ACID SEQUENCE; ANIMAL; ANTIGEN ANTIBODY REACTION; BAGG ALBINO MOUSE; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; CROSS REACTION; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MOLECULAR GENETICS; MOLECULAR MIMICRY; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SOLUBILITY;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; CELL LINE; CROSS REACTIONS; EPITOPES; HLA-A2 ANTIGEN; HUMANS; HYBRIDOMAS; IMMUNE TOLERANCE; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; ISOANTIBODIES; MALE; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; RABBITS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SOLUBILITY;

EID: 0032534229     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Lagaaij, E. L., P. H. Henneman, M. B. Ruigrok, et al. 1989. Effect of 1 HLA-DR antigen matched and completely HLA-DR mismatched blood transfusions on survival of heart and kidney allografts. N. Engl. J. Med. 321:701.
2. + recipient. Transplantation 45:1066.
3. Reed, E., V. R. Bonagura, P. Kung, D. W. King, and N. Suciu-Foca. 1983. Anti-idiotypic antibodies to HLA-DR4 and -DR2. J. Immunol. 131:2890.
4. Kissmeyer-Nielsen, F., S. Olsen, V. P. Petersen, and O. Fjeldborg. 1966. Hyperacute rejection of kidney allographs, associated with pre-existing humoral antibodies aginst donor cells. Lancet 2:662.
5. Russell, P. S., C. M. Chase, H. J. Winn, and R. B. Colvin. 1994. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J. Immunol. 152:5135.
6. Halloran, P. F., J. Schaut, K. Solez, and N. S. Srinivasa, 1992. The significance of the anti-class I response. II. Clinical and pathological features of renal transplants with anti-class I-like antibody. Transplantation 53:550.
7. Reed, E., M. A. Hardy, A. Benvenisty, C. Lattes, J. Brensilver, R. McCabe, K. Reemtsma, D. W. King, and N. Suciu-Foca. 1987. Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients. N. Engl. J. Med. 316:1450.
8. Downey, W. E., III, W. M. Baldwin III, and F. Sanfilippo. 1990. Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of antiidiotypic antibodies and reduced alloantibody responses. Transplantation 49:160.
9. Pollard, S. G., H. F. Davies, and R. Y. Calne. 1990. Perioperative appearance of serum class I antigen during liver transplantation. Transplantation 49:659.
10. Kamada, N. 1985. Transplantation tolerance and immunosuppression following liver grafting in rats. Immunol. Today 6:336.
11. Mohanakumar, T., C. Rhodes, G. Mendez-Picon, M. W. Flye, and H. M. Lee. 1987. Antiidiotypic antibodies to human major histocompatibility complex class I and II antibodies in hepatic transplantation and their role in allograft survival. Transplantation 44:54.
12. DeVito-Haynes, L. D., E. Jankowska-Gan, H. W. Sollinger, S. J. Knechtle, and W. J. Burlingham. 1994. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum. Immunol. 40:191.
13. DeVito-Haynes, L. D., E. Jankowska-Gan, D. Heisey, N. H. P. M. Jutte, A. H. M. M. Balk, W. Weimar, F. H. J. Claas, T. F. C. Warner, R. M. Mentzer, R. B. Love, and W. J. Burlingham. 1996. Donor-derived HLA class I proteins in the serum of heart transplant recipients. J. Heart Lung Transplant. 15: 1012.
14. DeVito-Haynes, L. D., E. Jankowska-Gan, D. Heisey, K. C. Meyer, R. B. Love, and W. J. Burlingham. 1997. Soluble HLA Class I in epithelial lining fluid of lung transplants: associations with graft outcome. Hum. Immunol. 52:95.
15. Goodnow, C. C. 1992. Transgenic mice and analysis of B-cell tolerance. Annu. Rev. Immunol. 10:489.
16. d in animals transgenic for its soluble analog. Hum. Immunol. 52:82.
17. Grumet, F. C., S. Krishnaswamy, K. See-Tho, E. Filvaroff, and D. D. Hiraki. 1994. Soluble form of an HLA-B7 class I antigen specifically suppresses humoral alloimmunization. Hum. Immunol. 40:228(Abstr.).
18. Owen, R. D., H. R. Wood, A. G. Foord, P. Sturgeon, and L. G. Baldwin. 1954. Evidence for actively acquired tolerance to Rh antigens. Proc. Natl. Acad. Sci. USA 40:420.
19. Claas, F. H., Y. Gijbels, J. van Der Velden-de Munck, and J. J. van Rood. 1988. Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science 241:1815.
20. Hadley, G. A., D. L. Phelan, B. F. Duffy, and T. Mohanakumar. 1990. Lack of T-cell tolerance of noninherited maternal HLA antigens in normal humans. Hum. Immunol. 28:373.
21. Roelen, D. L., S. P. M. J. Van Bree, E. Van Beelen, J. J. van Rood, and F. H. J. Claas. 1995. No evidence of an influence of the non-inherited maternal HLA antigens on the alloreactive T cell repertoire in healthy individuals. Transplantation 59:1728.
22. Burlingham, W. J., A. P. Grailer, D. Heisey, F. H. J. Claas, D. J. Norman, T. Mohanakumar, D. C. Brennan, H. de Fijter, T. van Gelder, J. D. Pirsch, H. W. Sollinger, and M. A. Bean. 1998. The effect of tolerance to non-inherited maternal HLA antigens on the survival of renal transplants from sibling donors. N. Engl. J. Med. 339:In press.
23. -. J. Immunol. 141:4129.
24. Steele, D. J. R., T. M. Laufer, S. T. Smiley, Y. Ando, M. J. Grusby, L. H. Glimcher, and H. Auchincloss, Jr. 1996. Two levels of help for B cell alloantibody production. J. Exp. Med. 183:699.
25. Klein, J., S. Livnat, V. Hauptfeld, L. Jerabek, and I. Weissman. 1974. Production of anti-H-2 antibodies in thymectomized mice. Eur. J. Immunol. 4:41.
26. Nakashima, I., and P. Lake. 1979. A novel subset of antigenic cells triggers B-cell responses to MHC antigens. Nature 279:716.
27. Andris, J. S., S. R. Abraham, V. Pascual, M. P. Pistillo, S. Mantero, G. B. Ferrara, and J. D. Capra. 1995. The human antibody repertoire: heavy and light chain variable region gene usage in six alloantibodies specific for human HLA class I and class II alloantigens. Mol. Immunol. 32:1105.
28. Jerne, N. K. 1974. Towards a network theory of the immune system. Ann. Inst. Pasteur Immunol. 125C:373.
29. Tsujisaki, M., K. Sakaguchi, M. Igarashi, P. Richiardi, F. Perosa, and S. Ferrone. 1988. Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1. Transplantation 45:632.
30. Armandola, E. A., S. M. Mariani, and S. Ferrone. 1993. Serological and molecular characterization of mouse anti-idiotypic monoclonal antibodies elicited with the syngeneic anti-HLA-A2,28 monoclonal antibody CR11-351. Mol. Immunol. 30:287.
31. Russo, C., A.-K. Ng, M. A. Pellegrino, and S. Ferrone. 1983. The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells. Immunogenetics 18:23.
32. McMichael, A. J., P. Parham, N. Rust, and F. M. Brodsky. 1980. A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17. Hum. Immunol. 1:121.
33. Temponi, M., T. Kageshita, F. Perosa, R. Ono, H. Okada, and S. Ferrone. 1989. Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification. Hybridoma 8:85.
34. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
35. Hullett, D. A., K. Klycezk, and C. Hayes. 1984. I-A controlled T cell molecules: protease sensitivity. J. Immunol. 133:3183.
36. Peyron, E., J.-F. Nicolas, A. Reano, P. Roche, J. Thivolet, M. Haftek, D. Schmitt, C. Perrone, J. Banchereau, and F. Rousset. 1994. Human monoclonal autoantibodies specific for the bullous pemphigoid antigen (BPAg1). J. Immunol. 153: 1333.
37. Mulder, A., M. Kardol, J. Blom, W. B. Jolley, C. J. M. Melief, and H. Bruning. 1993. A human monoclonal antibody, produced following in vitro immunization, recognizing an epitope shared by HLA-A2 subtypes and HLA-A28. Tissue Antigens 42:27.
38. Teng, N. N. H., K. S. Lam, F. C. Riera, and H. S. Kaplan. 1983. Construction and testing of mouse-human heteromyelomas for human monoclonal antibody production. Proc. Natl. Acad. Sci. USA 80:7308.
39. Wallace, E. F., S. K. H. Foung, K. Bradbury, S. L. Pask, and F. C. Grumet. 1990. Generation of a human hybridoma producing a pure anti-HLA-A2 monoclonal antibody. Hum. Immunol. 28:65.
40. Hogan, K. T., and S. L. Brown. 1992. Localization and characterization of serologic epitopes on HLA-A2. Hum. Immunol. 33:185.
41. DeVito, L. D., H. W. Sollinger, and W. J. Burlingham. 1990. Adsorption of cytotoxic anti-HLA antibodies with HLA class I immunosorbent beads. Transplantation 49:925.
42. b fusion protein. Hum. Immunol. 32: 125.
43. Zachary, A. A., and G. A. Teresi. 1990. Laboratory Manual. American Society for Histocompatibility and Immunogenetics, New York, NY.
44. Niguma, T., L. D. DeVito, A. P. Grailer, J. H. Fechner, Jr., H. W. Sollinger, and W. J. Burlingham. 1993. Activation of HLA-A2-specific memory B cells in severe combined immunodeficient (SCID) mice. Hum. Immunol. 37:7.
45. Williamson, R. A., M. A. A. Persson, and D. R. Burton. 1991. Expression of a human monoclonal anti-(rhesus D) Fab fragment in Escherichia coli with the use of bacteriophage lambda vectors. Biochem. J. 227:561.
46. Persson, M. A. A., R. H. Caothien, and D. R. Burton. 1991. Generation of diverse high affinity human monoclonal antibodies by repertoire cloning. Proc. Natl. Acad. Sci. USA 88:2432.
47. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
48. Martin, A. C. R., and J. M. Thornton. 1996. Structural families in loops of homologous proteins: automatic classification, modeling, and application to antibodies. J. Mol. Biol. 263:800.
49. DeVito, L. D., B. Mason, E. Jankowska-Gan, K. T. Hogan, J.-W. Guo, C. T. Lutz, H. W. Sollinger, and W. J. Burlingham. 1993. Epitope fine specificity of human anti-HLA-A2 antibodies: identification of 4 epitopes including a hapten like epitope on HLA-A2 at lysine 127. Hum. Immunol. 37:165.
50. Fuller, A. A., J. E. Trevithick, G. E. Rodey, P. Parham, and T. C. Fuller. 1990. Topographic map of the HLA-A2 CREG epitopes using human alloantibody probes. Hum. Immunol. 28:284.
51. Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506.
52. Hogan, K. T., C. Clayberger, E. J. Bernhard, S. F. Walk, J. P. Ridge, P. Parham, A. M. Krensky, and V. H. Engelhard. 1989. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2 specific antibodies and cytotoxic T lymphocytes. J. Immunol. 142:2097.
53. Garcia, K. C., P. M. Ronco, P. J. Verroust, A. T. Brunger, and L. M. Amzel. 1992. Three dimensional structure of an angiotensin II-Fab complex at 3Å: hormone recognition by an anti-idiotypic antibody. Science 257:502.
54. Amzel, L. M., K. C. Garcia, and S. Desiderio. 1994. Do anti-idiotypic antibodies mimic antigen? Res. Immunol. 145:53.
55. Ichihashi, T., K. Kubo, T. Naoe, and R. Ohno. 1993. Nucleotide sequences of the variable regions of a human monoclonal antibody against HLA-A1, A23, and A24. Tissue Antigens 41:249.
56. Goldbaum, F. A., C. A. Velikovsky, W. Dall'Acqua, C. A. Fossati, B. A. Fields, B. C. Braden, R. J. Poljak, and R. A. Mariuzza. 1997. Characterization of antiidiotypic antibodies that bind antigen and an anti-idiotype. Proc. Natl. Acad. Sci. USA 94:8697.
57. Bluestone, J. A., H. Auchincloss, Jr., D. H. Sachs, M. Fibi, and G. J. Hammerling. 1983. Anti-idiotypes against anti-H-2 antibodies. VI. Detection of shared idiotypes among monoclonal anti-H-2 antibodies. Eur. J. Immunol. 13:489.
58. Phelan, D. L., G. E. Rodey, and C. B. Anderson. 1989. The development and specificity of antiidiotypic antibodies in renal transplant recipients receiving single-donor blood transfusions. Transplantation 48:57.
59. Ferrone, S., K. K. Mittal, M. A. Pellegrino, J. P. Allison, and R. A. Reisfeld. 1977. Immunogenicity of HLA antigens purified from serum. Transplantation 23:7.
60. Chattopahyay, P., J. Starkey, and S. Raychaudhuri. 1991. Analysis of anti-tumor antibodies in mice and rabbits induced by monoclonal anti-idiotype antibodies. J. Immunol. 147:2055.
61. Sacks, D. L., and A. Sher. 1983. Evidence that anti-idiotype-induced immunity to experimental African trypanosomiasis is genetically restricted and requires recognition of combining site-related idiotopes. J. Immunol. 131:1511.
62. Pride, M. W., A. Thakur, and Y. Thanavala. 1993. Mimicry of the alpha determinant of hepatitis B surface antigen by an anti-idiotypic antibody. I. Evaluation in hepatitis B surface antigen responder and non-responder strains. J. Exp. Med. 177:127.
63. Yu, M. W. N., S. Lemieux, and P. J. Talbot. 1996. Genetic control of antiidiotypic vaccination against coronavirus infection. Eur. J. Immunol. 26:3230.
64. Dal Porto, J., T. E. Johansen, B. Catipovic, D. J. Parfiit, D. Tuveson, U. Gether, S. Kozlowski, D. T. Fearson, and J. P. Schneck. 1993. A soluble divalent Class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations. Proc. Natl. Acad. Sci. USA 90:6671.